预后系统综述的挑战与启示:以常染色体显性多囊肾病为例
本文以常染色体显性多囊肾病(ADPKD)血清和尿液预后生物标志物的系统综述与荟萃分析为例,描述了开展预后因素系统综述各步骤中遇到的挑战及应对策略。作者认为最具挑战性的是数据分析与解读,主要因数据报告方式差异大;其他挑战涉及筛选和数据提取,因大量研究并非以预后为主要目的但包含有价值数据。
要点
- 预后系统综述在证据丰富时挑战大,数据分析与解读因报告差异最困难。
- 筛选与提取挑战源于大量非预后研究含可用数据。
- 分享经验与技巧可帮助未来预后因素系统综述的开展。
核心结论
- 以ADPKD预后生物标志物系统综述为例,数据分析与解读因数据报告差异大而最具挑战性。
研究设计与样本
- 基于ADPKD血清和尿液预后生物标志物的系统综述与荟萃分析,记录各步骤挑战并讨论解决方案。
主要发现
- 最具挑战性的步骤是数据分析与解读,主要由于数据报告方式 variability 大。
- 筛选和数据提取的挑战与大量研究并非以预后为主要目的但包含有价值数据有关。
临床怎么用
- 开展预后系统综述时可参考本文挑战与技巧以简化流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Conducting systematic reviews of prognostic factors is challenging, especially in the presence of abundant evidence. In this paper, we describe challenges encountered and lessons learned from our experience in conducting a systematic review and meta-analysis for prognostic biomarkers used in Autosomal Dominant Polycystic Kidney Disease (ADPKD). METHODS: Throughout the process of conducting the systematic review, we drafted the challenges encountered at each step and tackled potential solutions and insights for the addressed challenges. We then met as a group to discuss whether any further individual issues needed to be added and what aspects would have made the process easier. RESULTS: Despite a few issues in multiple steps of the process, the authors thought the most challenging step was data analysis and interpretation, mainly due to the variability in how the data were reported. Other challenges were related to screening and extraction of data due to the large number of studies that were not primarily prognostic studies but included valuable data to this review. CONCLUSION: Using the worked example of a prognostic systematic review and meta-analysis for biomarkers used in ADPKD, we believe that the challenges mentioned and tips provided will make the process easier for researchers conducting future prognostic systematic reviews focusing on prognostic factors. PLAIN LANGUAGE SUMMARY: Systematic reviews of prognostic biomarkers help showcase which factors may predict disease progression. However, conducting these reviews can be challenging, especially when there is a lot of evidence and data are reported inconsistently. In this paper, we describe the difficulties we encountered while conducting a systematic review and meta-analysis of serum and urine prognostic biomarkers in Autosomal Dominant Polycystic Kidney Disease (ADPKD). Some challenges included analyzing and interpreting data because studies often reported results differently and study screening and data extraction, as many studies were not designed primarily as prognostic studies but still contained useful information. By sharing our experience and potential solutions, we hope to ease conducting future prognostic systematic reviews focusing on prognostic biomarkers.
引用
- Khawandi J, Rayner DG, Rao V, et al. Prognostic systematic reviews: challenges and insights: an example. J Clin Epidemiol. 2026. PMID: 42498085. doi:10.1016/j.jclinepi.2026.112427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。